ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

RP RepliCel Life Sciences Inc

0.055
0.00 (0.00%)
28 Jun 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 00121k252k353k354k353k353k
Operating Income -4.29M-5.99M-2.74M-3.02M-1.35M-2.3M-1.4M-1.39M
Pre Tax Income -4.27M-6.01M-2.77M-2.95M-1.58M-4.07M-743k-311k
Net Income -4.27M-6.01M-2.77M-2.95M-1.58M-4.07M-743k-311k
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.273-0.28-0.103-0.104-0.053-0.117-0.016-0.005
EBIT -4.29M-5.99M-2.74M-2.94M-1.57M-3.37M-454k-325k
EBITDA -4.28M-5.99M-2.74M-3.02M-1.35M-2.3M-1.4M-1.39M